Selling and Marketing Expense of IMMUCELL CORP /DE/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
IMMUCELL CORP /DE/ quarterly and annual Selling and Marketing Expense in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Selling and Marketing Expense for the quarter ending 30 Sep 2025 was $919,291, a 8.9% increase year-over-year.
  • IMMUCELL CORP /DE/ Selling and Marketing Expense for the twelve months ending 30 Sep 2025 was $3,308,182, a 0.2% increase year-over-year.
  • IMMUCELL CORP /DE/ annual Selling and Marketing Expense for 2024 was $3,466,072, a 12% increase from 2023.
  • IMMUCELL CORP /DE/ annual Selling and Marketing Expense for 2023 was $3,088,215, a 3.2% decline from 2022.
  • IMMUCELL CORP /DE/ annual Selling and Marketing Expense for 2022 was $3,190,033, a 27% increase from 2021.
Source SEC data
View on sec.gov
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,308,182 $919,291 +$75,246 +8.9% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $3,232,936 $696,086 -$288,871 -29% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $3,521,807 $856,658 +$55,735 +7% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $3,466,072 $836,147 +$164,634 +25% 01 Oct 2024 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $3,301,438 $844,045 +$26,559 +3.2% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,274,879 $984,957 +$265,168 +37% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $3,009,711 $800,923 -$78,504 -8.9% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $3,088,215 $671,513 -$321,043 -32% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $3,409,258 $817,486 +$90,748 +12% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $3,318,510 $719,789 +$60,550 +9.2% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $3,257,960 $879,427 +$67,927 +8.4% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $3,190,033 $992,556 +$102,627 +12% 01 Oct 2022 31 Dec 2022 10-Q 13 Nov 2024 2024 Q3
Q3 2022 $3,087,406 $726,738 +$70,320 +11% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $3,017,086 $659,239 +$222,257 +51% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $2,794,829 $811,500 +$290,903 +56% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $2,503,926 $889,929 +$229,568 +35% 01 Oct 2021 31 Dec 2021 10-Q 13 Nov 2023 2023 Q3
Q3 2021 $2,274,358 $656,418 +$197,301 +43% 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 $2,077,057 $436,982 -$28,542 -6.1% 01 Apr 2021 30 Jun 2021 10-Q/A 21 Nov 2022 2022 Q2
Q1 2021 $2,105,599 $520,597 -$62,300 -11% 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q4 2020 $2,167,899 $660,361 -$29,217 -4.2% 01 Oct 2020 31 Dec 2020 10-Q 21 Nov 2022 2022 Q3
Q3 2020 $2,197,116 $459,117 -$38,537 -7.7% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $2,235,653 $465,524 -$58,252 -11% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $2,293,905 $582,897 -$24,207 -4% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,318,112 $689,578 +$106,509 +18% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $2,211,603 $497,654 +$2,951 +0.6% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $2,208,652 $523,776 +$48,550 +10% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $2,160,102 $607,104 +$75,199 +14% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $2,084,903 $583,069 +$51,900 +9.8% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $2,033,003 $494,703 +$47,970 +11% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,985,033 $475,226 +$74,780 +19% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $1,910,253 $531,905 +$17,430 +3.4% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q4 2017 $1,892,823 $531,169 +$64,869 +14% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $1,827,954 $446,733 -$36,976 -7.6% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $1,864,930 $400,446 -$61,864 -13% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 $1,926,794 $514,475 +$95,477 +23% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q4 2016 $1,831,317 $466,300 -$53,669 -10% 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 $1,884,986 $483,709 +$101,969 +27% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $1,783,017 $462,310 +$146,024 +46% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $1,636,993 $418,998 +$30,095 +7.7% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $1,606,898 $519,969 +$124,435 +31% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $1,482,463 $381,740 +$8,145 +2.2% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $1,474,318 $316,286 +$53,598 +20% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $1,420,720 $388,903 +$103,598 +36% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q4 2014 $1,317,122 $395,534 +$134,277 +51% 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $1,182,845 $373,595 +$115,358 +45% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $1,067,487 $262,688 +$16,824 +6.8% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 $1,050,663 $285,305 +$63,897 +29% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1
Q4 2013 $986,766 $261,257 -$25,188 -8.8% 01 Oct 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
Q3 2013 $1,011,954 $258,237 +$5,675 +2.2% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $1,006,279 $245,864 +$52,863 +27% 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014 2014 Q2
Q1 2013 $953,416 $221,408 -$19,801 -8.2% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q4 2012 $973,217 $286,445 +$50,560 +21% 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
Q3 2012 $922,657 $252,562 +$54,707 +28% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $867,950 $193,001 -$39,056 -17% 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013 2013 Q2
Q1 2012 $907,006 $241,209 +$37,137 +18% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 $869,869 $235,885 01 Oct 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
Q3 2011 $197,855 +$566 +0.29% 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 $232,057 +$123,699 +114% 01 Apr 2011 30 Jun 2011 10-Q/A 07 Sep 2012 2012 Q2
Q1 2011 $204,072 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1
Q3 2010 $197,289 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $108,358 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

IMMUCELL CORP /DE/ Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,466,072 +$377,857 +12% 01 Jan 2024 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
2023 $3,088,215 -$101,818 -3.2% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $3,190,033 +$686,107 +27% 01 Jan 2022 31 Dec 2022 10-Q 13 Nov 2024 2024 Q3
2021 $2,503,926 +$336,027 +16% 01 Jan 2021 31 Dec 2021 10-Q 13 Nov 2023 2023 Q3
2020 $2,167,899 -$150,213 -6.5% 01 Jan 2020 31 Dec 2020 10-Q 21 Nov 2022 2022 Q3
2019 $2,318,112 +$233,209 +11% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $2,084,903 +$192,080 +10% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $1,892,823 +$61,506 +3.4% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $1,831,317 +$224,419 +14% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $1,606,898 +$289,776 +22% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $1,317,122 +$330,356 +33% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $986,766 +$13,549 +1.4% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
2012 $973,217 +$103,348 +12% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $869,869 +$218,980 +34% 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
2010 $650,889 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.